The Oncology Institute Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Go Beyond the Preview – Access the Full Value Chain Analysis
This The Oncology Institute Value Chain Analysis helps you understand how the company creates value across support and primary activities in a clear, practical framework. This page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to access the complete ready-to-use report.
Support Activities
Firm Infrastructure
The Oncology Institute's firm infrastructure matters because oncology is reimbursement-heavy and rules-driven, so tight governance, billing control, and payer contracting directly protect cash flow. Centralized oversight also helps keep multidisciplinary care and clinic operations aligned across markets. For a provider with complex payer mix and high prior-authorization load, small billing leaks can hit margins fast.
Human Resource Management
Human Resource Management is a core capacity driver for The Oncology Institute because hiring and keeping oncologists, hematologists, radiation oncologists, nurses, pharmacists, and care coordinators determines how many patients each community site can serve. In 2025, TOI still depends on clinical teams to keep treatment protocols, patient navigation, and supportive care consistent across its network. Strong training also helps reduce variation in care and supports retention in a tight specialist labor market.
Technology Development
Technology Development at The Oncology Institute supports care coordination, scheduling, charting, prior authorization, and outcome tracking, so patients move faster through each step of care. Clinical and revenue-cycle systems also improve handoffs between specialties and help manage specialty drug use, which matters in oncology, where treatment is complex and costly. In 2025, this kind of workflow control is a direct lever for better access, cleaner claims, and tighter follow-up.
Procurement
The Oncology Institute must tightly source specialty drugs, infusion supplies, lab materials, and equipment service contracts because oncology inputs are costly and time-sensitive. In 2025, drug and medical-supply inflation still pressured provider margins, so disciplined buying and vendor control helped protect cash and cut stockout risk. Better procurement also supports cash conversion by reducing tied-up inventory while keeping treatments on schedule.
TOI's 2025 Support Functions: Small Costs, Big Oncology Impact
The Oncology Institute's support activities are cash-critical in 2025: tight overhead, hiring, systems, and drug buying keep oncology delivery on time and claims clean. US cancer burden stays heavy, with about 2.0 million new cases expected in 2025, so workflow and supply control matter.
| Support activity | 2025 impact |
|---|---|
| HR | retention |
| IT | faster auth |
| Procurement | lower waste |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
Inbound logistics at The Oncology Institute starts with referrals, lab results, imaging, pathology, drugs, and clinical supplies. Cancer care timing matters: the U.S. is projected to see 2,001,140 new cancer cases in 2025, so fast intake helps the practice start treatment sooner and cut avoidable delays. Better routing of records and supplies also supports smoother visits, fewer reschedules, and tighter operating flow.
Operations
The Oncology Institute's Operations center on medical oncology, radiation oncology, hematology, surgical oncology, and supportive care, with diagnosis, treatment planning, and treatment delivery kept in local communities. This model lowers friction for patients and keeps care coordinated across one clinical path. In FY2025, that integrated setup remained the key engine of the Oncology Institute value chain.
Outbound Logistics
Outbound logistics at The Oncology Institute is the last step after a care decision: prescriptions, follow-up scheduling, records transfer, and handoffs to pharmacies or referring physicians. In FY2025, this matters because every missed transfer can push patients out of network and slow therapy start. Tight coordination helps keep patients moving through the care path and protects referral volume.
Marketing and Sales
The Oncology Institute relies on physician referrals, payer contracts, and local market ties, not mass ads, to fill its clinics. Its marketing and sales work is built around being a convenient, integrated oncology choice in the markets The Oncology Institute serves, which helps drive patient flow and payer acceptance.
This model fits value-based care: in 2025, oncology groups are still judged on access, coordination, and cost control, so referral speed and insurer alignment matter more than broad consumer spend.
Service
Service in The Oncology Institute value chain covers survivorship, symptom control, ongoing monitoring, and supportive care between visits. These touchpoints help catch treatment issues early, improve the patient experience, and reduce avoidable care gaps. For oncology practices, retaining long-duration patients inside one care network can support steadier follow-up revenue and lower leakage to outside providers.
The Oncology Institute's FY2025: Faster Cancer Care, Better Retention
Primary activities at The Oncology Institute in FY2025 centered on fast intake, integrated treatment, and tight follow-up, which matter as U.S. cancer cases are projected at 2,001,140 in 2025. Its clinic model keeps diagnosis, therapy, and survivorship in one path. Referral speed and payer alignment help limit leakage.
| FY2025 cue | Value |
|---|---|
| U.S. new cancer cases | 2,001,140 |
Preview the Actual Deliverable
The Oncology Institute Reference Sources
This is the actual The Oncology Institute Value Chain Analysis document you'll receive upon purchase – no surprises, just professional quality. The preview below is taken directly from the full report, so you're seeing the same content before buying. Purchase unlocks the complete, detailed version immediately.
Frequently Asked Questions
The integrated outpatient care model drives the most value. The Oncology Institute ties together 5 care areas-medical oncology, radiation oncology, hematology, surgical oncology, and supportive care-so patients can stay inside one coordinated workflow. That lowers handoff friction and supports continuity across the 4 support functions behind the practice.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.